Pradip Raychaudhuri

Biochemistry, Genetics and Molecular Biology · Life Sciences

49h-index6.8kcitations183works1.02yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

FOXO transcription factor regulation(69), Cancer-related Molecular Pathways(40), DNA Repair Mechanisms(19), Virus-based gene therapy research(16), Epigenetics and DNA Methylation(14)

Publications183 total

Emerging Technologies in Healthcare Organizations for Quality Patient Care and Safety, Improved Operations, and Technological Sustainability: A Qualitative Study Based on the Design Thinking Approach
International Journal of Medical Science and Health Research·2025Open Access
Diagnostic approach to rickets: an Endocrine Society of Bengal (ESB) consensus statement
Annals of Pediatric Endocrinology & Metabolism·2024· 2 citedOpen Access
Supplementary Figure 4 from Targeting FoxM1 Effectively Retards p53-Null Lymphoma and Sarcoma
2023Open Access
Supplementary Figure 1 from Targeting FoxM1 Effectively Retards p53-Null Lymphoma and Sarcoma
2023Open Access
Supplementary Figure 5 from Targeting FoxM1 Effectively Retards p53-Null Lymphoma and Sarcoma
2023Open Access
Supplementary Figure Legends from Targeting FoxM1 Effectively Retards p53-Null Lymphoma and Sarcoma
2023Open Access
Supplementary Figure 1 from Targeting FoxM1 Effectively Retards p53-Null Lymphoma and Sarcoma
2023Open Access
Supplementary Figure 3 from Targeting FoxM1 Effectively Retards p53-Null Lymphoma and Sarcoma
2023Open Access
Supplementary Figure Legends from Targeting FoxM1 Effectively Retards p53-Null Lymphoma and Sarcoma
2023Open Access
Supplementary Figure 2 from Targeting FoxM1 Effectively Retards p53-Null Lymphoma and Sarcoma
2023Open Access
Supplementary Figure 3 from Targeting FoxM1 Effectively Retards p53-Null Lymphoma and Sarcoma
2023Open Access
Supplementary Figure 5 from Targeting FoxM1 Effectively Retards p53-Null Lymphoma and Sarcoma
2023Open Access
Supplementary Figure 4 from Targeting FoxM1 Effectively Retards p53-Null Lymphoma and Sarcoma
2023Open Access
Data from Targeting FoxM1 Effectively Retards p53-Null Lymphoma and Sarcoma
2023Open Access
Data from Targeting FoxM1 Effectively Retards p53-Null Lymphoma and Sarcoma
2023Open Access
Supplementary Figure 2 from Targeting FoxM1 Effectively Retards p53-Null Lymphoma and Sarcoma
2023Open Access
Data from DDB2 Is a Novel Regulator of Wnt Signaling in Colon Cancer
2023Open Access
Supplementary Methods from DDB2 Is a Novel Regulator of Wnt Signaling in Colon Cancer
2023Open Access
Supplementary Data from Transcriptional Repression by FoxM1 Suppresses Tumor Differentiation and Promotes Metastasis of Breast Cancer
2023Open Access
Data from Transcriptional Repression by FoxM1 Suppresses Tumor Differentiation and Promotes Metastasis of Breast Cancer
2023Open Access
page 1 of 10Next →

Frequent Co-authors

Srilata Bagchi(18), Robert H. Costa(12), Angela L. Tyner(9), Dragana Kopanja(9), Zebin Wang(8), Hyun Jung Park(7), Lester F. Lau(7), Janai R. Carr(6), Joseph R. Nevins(6), Alo Nag(6), Pavel Shiyanov(5), Abhishek Datta(4), Nissim Hay(4), Jing Li(4), Tanya Stoyanova(4), Nilotpal Roy(4), Vladimir V. Kalinichenko(3), Michael L. Major(3), Megan M. Kiefer(3), Yi–Ju Chen(3)